Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma

BACKGROUND AND AIM: We evaluated the efficacy of rechallenge transcatheter arterial chemoembolization (TACE) after lenvatinib (LEN) treatment in patients with previous TACE failure/refractoriness. METHODS: We enrolled 63 consecutive patients with a history of TACE failure/refractoriness prior to LEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida‐Kobayashi, Sawako, Kageyama, Ken, Takemura, Shigekazu, Matsumoto, Kazuhiro, Odagiri, Naoshi, Jogo, Atsushi, Kotani, Kohei, Kozuka, Ritsuzo, Motoyama, Hiroyuki, Kawamura, Etsushi, Hagihara, Atsushi, Yamamoto, Akira, Fujii, Hideki, Tanaka, Shogo, Enomoto, Masaru, Tamori, Akihiro, Miki, Yukio, Kubo, Shoji, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667401/
https://www.ncbi.nlm.nih.gov/pubmed/36406645
http://dx.doi.org/10.1002/jgh3.12819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667401/
https://www.ncbi.nlm.nih.gov/pubmed/36406645
http://dx.doi.org/10.1002/jgh3.12819

Ejemplares similares